Search by Drug Name or NDC

NDC 00527-1934-30 Solifenacin Succinate 10 mg/1 Details

Solifenacin Succinate 10 mg/1

Solifenacin Succinate is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lannett Company, Inc.. The primary component is SOLIFENACIN SUCCINATE.

MedlinePlus Drug Summary

Solifenacin (VESIcare) is used to treat overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Solifenacin (VESIcare LS) is used to treat neurogenic detrusor overactivity (a bladder control condition caused by brain, spinal cord or nerve problem) in children 2 years of age and older. Solifenacin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles.

Related Packages: 00527-1934-30
Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Solifenacin

Product Information

NDC	00527-1934
Product ID	0527-1934_ee4e17cc-e1c9-419e-838d-f21313e021d4
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Solifenacin Succinate
Proprietary Name Suffix	n/a
Non-Proprietary Name	solifenacin succinate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	10
Active Ingredient Units	mg/1
Substance Name	SOLIFENACIN SUCCINATE
Labeler Name	Lannett Company, Inc.
Pharmaceutical Class	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA211622
Listing Certified Through	2024-12-31

Package

NDC 00527-1934-30 (00527193430)

Pricing Information	N/A
NDC Package Code	0527-1934-30
Billing NDC	00527193430
Package	30 TABLET, FILM COATED in 1 BOTTLE (0527-1934-30)
Marketing Start Date	2023-06-06
NDC Exclude Flag	N